This study shows that growth retardation and rickets were the most prevalent clinical manifestations at diagnosis in a large series of Spanish pediatric patients with XLH confirmed by mutations in the PHEX gene. Traditional treatment with phosphate and vitamin D supplements did not improve height or corrected hypophosphatemia and was associated with a risk of hyperparathyroidism and nephrocalcinosis. The severity of the disease was similar in males and females.
Utilizamos cookies propias y de terceros para mejorar nuestra web mediante el análisis de tu navegación en nuestro sitio. Si continuas navegando, consideraremos que aceptas su uso. Para más información, consulta nuestro Aviso Legal.